SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-006788
Filing Date
2020-02-26
Accepted
2020-02-26 16:15:27
Documents
3
Period of Report
2020-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adpt-8k_20200226.htm 8-K 34095
2 EX-99.1 PRESS RELEASE DATED FEBRUARY 26, 2020 adpt-ex991_19.htm EX-99.1 369209
3 GRAPHIC g5qgho2mivci000001.jpg GRAPHIC 3265
  Complete submission text file 0001564590-20-006788.txt   409193
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 20655851
SIC: 2836 Biological Products, (No Diagnostic Substances)